We are live on
!
Find out more
PCH
Polar Capital Holdings Portfolio holdings
AUM
$42.4B
1-Year Est. Return
181.11%
This Fund
S&P 500
This Quarter
Est. Return
+14.73%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
–
AUM
$19.8B
AUM Growth
+$4.43B
(+29%)
Cap. Flow
-$459M
Cap. Flow
% of AUM
-2.31%
Top 10 Holdings %
Top 10 Hldgs %
44.52%
Holding
334
New
39
Increased
100
Reduced
95
Closed
48
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$124M |
| 2 |
McKesson
MCK
|
+$123M |
| 3 |
Amazon
AMZN
|
+$72.5M |
| 4 |
Rambus
RMBS
|
+$72.1M |
| 5 |
Indivior Pharmaceuticals
INDV
|
+$69.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$102M |
| 2 |
Teradyne
TER
|
+$90.7M |
| 3 |
Apple
AAPL
|
+$80M |
| 4 |
United Therapeutics
UTHR
|
+$72.6M |
| 5 |
Visa
V
|
+$71.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.14% |
| 2 | Miscellaneous | 28.15% |
| 3 | Healthcare | 17.87% |
| 4 | Financials | 12.12% |
| 5 | Communication Services | 6.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Vertex Pharmaceuticals
VRTX
$132B
| $132M | 0.67% |
375,000
| – | – |
|
27
CrowdStrike
CRWD
$241B
| $130M | 0.65% |
3,535,456
-330,364
| -9% | -$11.5M |
|
28
Legend Biotech
LEGN
$3.6B
| $129M | 0.65% |
1,872,118
-103,513
| -5% | -$6.76M |
|
29
ON Semiconductor
ON
$27.9B
| $127M | 0.64% |
1,343,257
-130,763
| -9% | -$10.8M |
|
30
DexCom
DXCM
$31.3B
| $125M | 0.63% |
973,734
+114,687
| +13% | +$13.9M |
|
31
Essent Group
ESNT
$6.13B
| $124M | 0.63% |
2,660,000
-290,000
| -10% | -$12.6M |
|
32
W.R. Berkley
WRB
$25.9B
| $119M | 0.6% |
3,000,000
+243,750
| +9% | +$9.58M |
|
33
Xenon Pharmaceuticals
XENE
$5.64B
| $116M | 0.59% |
3,022,071
+5,253
| +0.2% | +$209K |
|
34
Intuitive Surgical
ISRG
$134B
| $116M | 0.59% |
339,194
-42,229
| -11% | -$12.8M |
|
35
Arista Networks
ANET
$237B
| $116M | 0.58% |
2,861,272
-620,840
| -18% | -$24M |
|
|
P
36
Everpure Inc
P
$31.3B
| $112M | 0.56% |
3,040,568
+1,484,226
| +95% | +$42M |
|
|
RVNC
37
DELISTED
Revance Therapeutics, Inc.
RVNC
| $105M | 0.53% |
4,167,842
| – | – |
|
38
Uber
UBER
$148B
| $102M | 0.52% |
2,368,175
-1,037,754
| -30% | -$38.6M |
|
39
Travelers Companies
TRV
$78.9B
| $102M | 0.51% |
586,040
-27,844
| -5% | -$4.91M |
|
40
HCA Healthcare
HCA
$92.4B
| $101M | 0.51% |
331,450
+97,808
| +42% | +$27.2M |
|
41
Baidu
BIDU
$31.4B
| $97.8M | 0.49% |
714,283
+138,061
| +24% | +$18.1M |
|
42
Everest Group
EG
$14.3B
| $95.7M | 0.48% |
280,000
| – | – |
|
43
Mercado Libre
MELI
$96.3B
| $95.6M | 0.48% |
80,663
-41,609
| -34% | -$52.3M |
|
|
44
Visa
V
$701B
| $95.5M | 0.48% |
401,942
-313,825
| -44% | -$71.8M |
|
45
Tesla
TSLA
$1.42T
| $95.3M | 0.48% |
363,956
+121,263
| +50% | +$24.2M |
|
46
Regeneron Pharmaceuticals
REGN
$81.7B
| $95.2M | 0.48% |
132,500
| – | – |
|
|
SGEN
47
DELISTED
Seagen Inc. Common Stock
SGEN
| $94.1M | 0.47% |
489,000
-60,392
| -11% | -$12M |
|
48
Acadia Healthcare
ACHC
$2.64B
| $93.8M | 0.47% |
1,178,312
+138,008
| +13% | +$9.97M |
|
49
Biogen
BIIB
$32.1B
| $92.6M | 0.47% |
325,000
+75,000
| +30% | +$22.3M |
|
50
Alkermes
ALKS
$7.69B
| $90.4M | 0.46% |
2,888,016
| – | – |
|
Similar funds
GAM
SAM
Polar Capital Holdings's Q2 2023 Portfolio in Review
As of Q2 2023, Polar Capital Holdings held 334 positions worth $19.8B, up 29% from $15.4B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Polar Capital Holdings's Q2 2023 filing shows 39 new, 100 increased, 95 reduced and 48 closed positions. Its largest new stake was Synopsys: 308,727 shares worth $134M. The largest sale was Microsoft, an estimated $102M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 36% a quarter earlier, followed by Miscellaneous and Healthcare.
- Polar Capital Holdings's largest Q2 2023 buy was Synopsys: 308,727 shares worth $134M.
- Polar Capital Holdings added most to Amazon in Q2 2023, an estimated $72.5M increase.
- Polar Capital Holdings's biggest Q2 2023 reduction was Microsoft, cutting an estimated $102M.
- Polar Capital Holdings fully exited Teradyne in Q2 2023, selling an estimated $90.7M.
- Polar Capital Holdings's ten largest holdings make up 45% of its $19.8B portfolio in Q2 2023.
- Polar Capital Holdings opened 39 new positions and closed 48 in Q2 2023.
- Polar Capital Holdings's portfolio value rose 29% quarter-over-quarter to $19.8B.
Based on Polar Capital Holdings's 13F filing for Q2 2023, filed 14 Aug 2023.